Picture of Revelation Biosciences logo

REVB — Revelation Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Gemini Priming Attenuates Inflammation In Human Peripheral Blood Mononuclear Cells

March 17 (Reuters) - Revelation Biosciences Inc REVB.O:

GEMINI PRIMING ATTENUATES INFLAMMATION IN HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS

Source text: ID:nBw2N0fGHa

Further company coverage: REVB.O

 ((Reuters.Briefs@thomsonreuters.com))

Recent news on Revelation Biosciences

See all news